Quantcast

Latest Antipsychotic Stories

2014-06-09 23:01:31

The Firm is investigating Risperdal lawsuits on behalf of men and boys who allegedly developed gynecomastia due to their use of Risperdal. New York, New York (PRWEB) June 09, 2014 As Risperdal lawsuits (http://www.risperdallawsuitcenter.com/) continue to mount in U.S. courts, Bernstein Liebhard LLP notes that a new report out of Australia has detailed a steep rise in the use of antipsychotic drugs among that country’s children. The report, which was prepared by the Drug Utilisation Sub...

2014-06-05 23:02:04

St. Jude Children’s Research Hospital scientists report that a disruption in a brain circuit may contribute to the auditory hallucinations of schizophrenia Memphis, Tenn. (PRWEB) June 05, 2014 St. Jude Children’s Research Hospital scientists have identified problems in a connection between brain structures that may predispose individuals to hearing the “voices” that are a common symptom of schizophrenia. The work appears in the June 6 issue of the journal Science. Researchers...

2014-06-04 23:03:29

The Firm is representing numerous clients in Risperdal lawsuits, all of whom allegedly developed gynecomastia (male breast growth) due to their use of the atypical antipsychotic medication. New York, New York (PRWEB) June 04, 2014 Plaintiffs in Risperdal lawsuits (http://www.risperdallawsuitcenter.com/) who allegedly developed gynecomastia (male breast growth) due to their use of the atypical antipsychotic have asked a Pennsylvania state court judge to reinstate their punitive damage...

2014-05-27 23:02:45

The Firm has filed a number of Risperdal lawsuits in the Pennsylvania proceeding on behalf of clients who allegedly developed gynecomastia (male breast growth) due to their use of Risperdal. New York, New York (PRWEB) May 27, 2014 As Risperdal lawsuits (http://www.injurybeacon.com/risperdal/lawsuit/) continue to mount in a mass tort litigation underway in Pennsylvania’s Philadelphia Court of Common Pleas, Bernstein Liebhard LLP notes that the defense is seeking partial summary judgment...

2014-05-22 23:13:01

Recent motions in Pennsylvania courts mark progress for Risperdal gynecomastia lawsuits; Risperdal lawyers offer no-obligation Risperdal gynecomastia lawsuit case review. St. Louis, MO (PRWEB) May 22, 2014 Attorneys handling national Risperdal lawsuits for The Onder Law Firm report progress in the Risperdal lawsuits filed in Pennsylvania’s Complex Litigation Center. According to court documents*, a Motion for Summary Judgment regarding Statute of Limitations was filed earlier this...

2014-05-14 08:30:09

PITTSBURGH, May 14, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Olanzapine Orally Disintegrating Tablets (ODT), 5 mg, 10 mg, 15 mg and 20 mg, the generic version of Eli Lilly and Company's Zyprexa Zydis(®) Tablets. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the treatment of schizophrenia or the acute treatment of manic or...

2014-05-13 08:33:18

New submission based on positive data from a 15-month schizoaffective relapse prevention study TITUSVILLE, N.J., May 13, 2014 /PRNewswire/ -- Janssen Pharmaceuticals, Inc., today announced the submission of supplemental New Drug Applications (sNDAs) for once-monthly atypical long-acting antipsychotic INVEGA(®) SUSTENNA(®) (paliperidone palmitate) to the U.S. Food and Drug Administration (FDA) for approval to treat schizoaffective disorder as either monotherapy or adjunctive...

2014-05-12 16:29:07

-- Secures Additional $50.4 Million in Cash in 1Q 2014 -- SEATTLE, May 12, 2014 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics targeting inflammation, coagulopathies and disorders of the central nervous system, today announced recent highlights and financial results for the first quarter of 2014, which include: -- 1Q 2014 net loss of $16.6...

2014-05-09 08:26:05

-- Expansion to Approximately 600 Sales Specialists Follows Initiation of National Television Advertising Campaign -- SAN DIEGO, May 9, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today reported that Eisai plans to add more than 200 new contract sales representatives to its Metabolic Business Unit, increasing the sales force for BELVIQ® by 50% to approximately 600, triple the size from the commercial launch of BELVIQ in June 2013. Eisai expects this expansion of the sales...

2014-05-07 23:14:54

Flood Law Group announced today that it is now available to investigate claims related to complications from taking prescription Invega extended release tablets. Invega, also known by its generic name paliperidone, may contribute to an increased risk of leukopenia and neutropenia and gynecomastica according to the FDA. Washington, D.C. (PRWEB) May 07, 2014 Flood Law Group released a statement today announcing that it is now available to investigate potential claims on behalf of people who...


Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related